Chiba, Japan

Mariko Kitajima

This inventor holds 2 USPTO granted patents. Top assignees: Chiba University, Josai University Corporation. Active years: 2012-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mariko Kitajima. Retrieved from https://idiyas.com/inventor/mariko-kitajima-9uqtgz3k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mariko Kitajima: Innovator in Indole Alkaloid Derivatives

Introduction

Mariko Kitajima is a prominent inventor based in Chiba, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of indole alkaloid derivatives. With a total of 2 patents, her work focuses on compounds that have potential therapeutic applications.

Latest Patents

Kitajima's latest patents include innovative formulations of indole alkaloid derivatives that exhibit opioid receptor agonistic effects. These patents detail the synthesis of these derivatives and their therapeutic compositions. The methods provided aim to treat various conditions using these compounds, showcasing her commitment to advancing medical science.

Career Highlights

Throughout her career, Mariko Kitajima has been associated with esteemed institutions such as Chiba University and Josai University Corporation. Her work in these organizations has allowed her to explore and develop her research in medicinal chemistry further.

Collaborations

Some of her notable coworkers include Hiromitsu Takayama and Kenjiro Matsumoto. Their collaborative efforts have contributed to the success of her research and patent applications.

Conclusion

Mariko Kitajima's innovative work in indole alkaloid derivatives highlights her role as a key figure in medicinal chemistry. Her patents reflect her dedication to developing therapeutic solutions that can benefit society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…